Tempus Oncology is an unclaimed profile.
If you work at Tempus, sign up or log in to claim the profile today.
Tempus
Tempus Oncology
Tempus Oncology is a precision medicine company that leverages AI and vast clinical and molecular data to support oncologists in making data-driven treatment decisions. Its offerings include comprehensive genomic profiling, minimal residual disease (MRD) testing, and AI-powered solutions like Tempus ONE, a voice-enabled device providing real-time access to patient data and clinical insights
Product Overview
Security and Compliance Certifications: HIPAA
Tempus Oncology is a precision medicine company that leverages AI and vast clinical and molecular data to support oncologists in making data-driven treatment decisions. Its offerings include comprehensive genomic profiling, minimal residual disease (MRD) testing, and AI-powered solutions like Tempus ONE, a voice-enabled device providing real-time access to patient data and clinical insights. The
Tempus Next
platform uses AI to optimize care pathways and close clinical gaps by analyzing EHR, imaging, and molecular data. Additionally, Tempus provides clinical trial matching and collaborates extensively with biopharma for drug discovery and research.
Customers Served
Categories
Company Info
HQ Location
Chicago, Illinois
Founded
2015
Headcount
1001-5000
Total Funding
$1.3B
Latest Round
Debt Financing
Latest Round
10/20/2022
Company Socials
Customers
2
Verified customers
Type
0
1
2
Hospitals / Health System (2)
Provider Headcount
0
1
2
5001+ (2)
Showcased Customers
See all (2)CARPL
CARPL
Company Info
Founded: 2018
Headcount: 11-50
Customers
Verified Customers: 5
Customers Served: Hospital / Health System, Ambulatory Practice
Product Overview
Security and Compliance Certifications: HIPAA, ISO 27001
CARPL provides a radiology AI platform that simplifies the integration, validation, and deployment of AI solutions within radiology departments. It offers access to over 110 AI applications from various vendors, enabling integration with existing PACS and RIS systems. The platform is designed to support scalable AI deployments, streamline workflows, and enhance diagnostic accuracy by providing a unified interface for managing AI solutions across different radiology tasks.
Other Categories
Cleerly
Cleerly
Company Info
Founded: 2017
Customers
Verified Customers: 1
Customers Served: Ambulatory Practice, Hospital / Health System
Product Overview
Security and Compliance Certifications: SOC 2 Type 2, HIPAA
Cleerly is an AI-based digital care platform for the diagnosis of heart disease. It utilizes coronary computed tomography angiography (CCTA) to provide analyses of atherosclerosis, plaque buildup and stenosis, through machine learning algorithms. The technology creates 3D models of coronary arteries for early heart disease detection and treatment plans. It includes the Cleerly Proxy and Cleerly ISCHEMIA for coronary artery disease.
Other Categories
Digital Diagnostics
Digital Diagnostics LumineticsCore
Company Info
Founded: 2010
Headcount: 51-200
Customers
Verified Customers: 3
Customers Served: Ambulatory Practice, Hospital / Health System
Product Overview
Security and Compliance Certifications: HIPAA
LumineticsCore by Digital Diagnostics is an AI diagnostic system that autonomously detects diabetic retinopathy, including macular edema, at the point-of-care using fundus images captured by a trained operator. It provides rapid results without needing specialist review, which facilitates immediate care decisions and referrals if disease is detected. The system is designed for healthcare providers, eye care professionals, payors, and patients, enhancing access to diagnostic evaluations for people with diabetes.
Other Categories